The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
Drug-induced liver injury (DILI) has become one of the major challenges of drug safety all over the word. So far, about 1,100 commonly used drugs including the medications used regularly, herbal and/or dietary supplements, have been reported to induce liver injury. Moreover, DILI is the main cause o...
Saved in:
Main Authors: | Wenhui Liu (Author), Xiangchang Zeng (Author), Yating Liu (Author), Jinfeng Liu (Author), Chaopeng Li (Author), Lulu Chen (Author), Hongying Chen (Author), Dongsheng Ouyang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
by: Ye Zixin, et al.
Published: (2022) -
Ginsenoside compound K attenuates cognitive deficits in vascular dementia rats by reducing the Aβ deposition
by: Wenjing Zong, et al.
Published: (2019) -
Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor
by: Jianwei Liao, et al.
Published: (2021) -
The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway
by: Xiangchang Zeng, et al.
Published: (2018) -
The NPC1L1 Gene Exerts a Notable Impact on the Reduction of Low-Density Lipoprotein Cholesterol in Response to Hyzetimibe: A Factorial-Designed Clinical Trial
by: Jianwei Liao, et al.
Published: (2022)